National Health Investors (NYSE:NHI) Downgraded to “Sell” at Zacks Investment Research

Zacks Investment Research downgraded shares of National Health Investors (NYSE:NHI) from a hold rating to a sell rating in a research report sent to investors on Wednesday morning, Zacks.com reports.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

NHI has been the subject of a number of other research reports. TheStreet upgraded National Health Investors from a c rating to a b- rating in a research report on Wednesday, July 1st. Mizuho lowered National Health Investors from a buy rating to a neutral rating and reduced their target price for the company from $60.00 to $55.00 in a report on Friday, May 22nd. ValuEngine lowered National Health Investors from a hold rating to a sell rating in a report on Thursday, April 2nd. KeyCorp cut their price objective on National Health Investors from $43.00 to $40.00 and set an underweight rating for the company in a report on Thursday, May 14th. Finally, Wells Fargo & Co increased their price objective on National Health Investors from $54.00 to $66.00 and gave the stock an equal weight rating in a report on Wednesday, June 17th. Three investment analysts have rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company’s stock. National Health Investors presently has an average rating of Hold and an average target price of $70.14.

Shares of NYSE NHI opened at $62.00 on Wednesday. The stock has a fifty day moving average price of $59.57 and a two-hundred day moving average price of $63.97. The company has a debt-to-equity ratio of 1.03, a quick ratio of 12.05 and a current ratio of 12.05. The firm has a market cap of $2.77 billion, a P/E ratio of 14.73 and a beta of 0.84. National Health Investors has a 1 year low of $31.37 and a 1 year high of $91.12.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Monday, May 11th. The real estate investment trust reported $1.37 EPS for the quarter, missing analysts’ consensus estimates of $1.40 by ($0.03). National Health Investors had a net margin of 57.16% and a return on equity of 12.62%. The company had revenue of $83.08 million for the quarter, compared to analyst estimates of $80.77 million. During the same quarter last year, the company posted $1.31 EPS. National Health Investors’s revenue was up 9.2% on a year-over-year basis. On average, research analysts predict that National Health Investors will post 5.61 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Tuesday, June 30th will be issued a $1.102 dividend. This represents a $4.41 dividend on an annualized basis and a dividend yield of 7.11%. The ex-dividend date is Monday, June 29th. National Health Investors’s dividend payout ratio is currently 80.18%.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Botty Investors LLC lifted its position in National Health Investors by 33.9% in the 2nd quarter. Botty Investors LLC now owns 10,160 shares of the real estate investment trust’s stock valued at $628,000 after acquiring an additional 2,575 shares in the last quarter. Brinker Capital Inc. bought a new stake in National Health Investors in the 2nd quarter valued at $244,000. ARP Americas LP bought a new stake in National Health Investors in the 2nd quarter valued at $413,000. Raymond James & Associates lifted its position in National Health Investors by 10.0% during the 2nd quarter. Raymond James & Associates now owns 81,132 shares of the real estate investment trust’s stock worth $4,926,000 after buying an additional 7,406 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its position in National Health Investors by 61.4% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 29,487 shares of the real estate investment trust’s stock worth $1,790,000 after buying an additional 11,220 shares in the last quarter. 68.92% of the stock is owned by hedge funds and other institutional investors.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

See Also: Trade War

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.